Magenta Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch MGTA and buy or sell other stocks, ETFs, and their options commission-free!About MGTA
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies.
CEOMarino Garcia, MBA
CEOMarino Garcia, MBA
Employees78
Employees78
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2015
Founded2015
Employees78
Employees78
MGTA Key Statistics
Market cap513.83M
Market cap513.83M
Price-Earnings ratio-10.39
Price-Earnings ratio-10.39
Dividend yield—
Dividend yield—
Average volume463.08K
Average volume463.08K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$40.16
52 Week high$40.16
52 Week low$13.37
52 Week low$13.37
Stock Snapshot
As of today, Magenta Therapeutics(MGTA) shares are valued at $11.99. The company's market cap stands at 513.83M, with a P/E ratio of -10.39.
During the trading day, Magenta Therapeutics(MGTA) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 463.08K.
Over the past 52 weeks, Magenta Therapeutics(MGTA) stock has traded between a high of $40.16 and a low of $13.37.
Over the past 52 weeks, Magenta Therapeutics(MGTA) stock has traded between a high of $40.16 and a low of $13.37.
People also own
Based on the portfolios of people who own MGTA. This list is generated using Robinhood data, and it’s not a recommendation.